Fundz

Elucidata Corp reported raising $1.69 Million in an initial SEC Form D filing, from an offering of $1.7 Million

PRIVATEMay 21, 2018$1.7M of $1.7M raised

Amount Raised

$1.69 Million

$1.69 Million sold, per SEC Form D (first sale May 21, 2018)

Round Type

Venture

CambridgeInformation TechnologyBiotechnologyHealth CareLife Science

Quick answer

Elucidata raised $1.69 Million in a funding round, dated May 21, 2018. Elucidata is based in Cambridge, Maryland, United States.

How much did Elucidata raise?
Elucidata raised $1.69 Million in a funding round on May 21, 2018.
What does Elucidata do?
We are a pioneering life sciences MLOps company for the future that transforms biological discovery by integrating different forms of biomedical data.
Where is Elucidata based and how big is it?
Elucidata is based in Cambridge, Maryland, United States.

Source: Fundz verified event record.

Who else raised in Life Science and Biotechnology around the same time

Companies in the same sectors as Elucidata that raised within 45 days of this round, from Fundz verified event records.

  • Danaher raised $13M on April 17, 2018.
  • Urotronic, Inc. raised $6.1M on July 5, 2018.
  • Viome raised $5.5M on July 3, 2018.
  • ENDRA Life Sciences raised $1.1M on July 3, 2018.
  • Medcura raised $1.6M (Seed) on July 2, 2018.
  • Viracta Therapeutics raised $2.7M (Seed) on July 2, 2018.

Who to call at Elucidata, and when

A new round usually means Elucidata is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Elucidata raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Elucidata, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Elucidata. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Elucidata

Location

Cambridge, Maryland, United States

About

We are a pioneering life sciences MLOps company for the future that transforms biological discovery by integrating different forms of biomedical data. We support discovery programs at Pfizer, Bristol Myers Squibb, Genentech, Stanford and Yale and have 35+ research partners from premier biopharma companies and research labs. We are a 150+ multi-disciplinary team of experts based across the US, Canada, and India. In December 2020, we raised $5mn in a pre-series A round led by IvyCap Ventures. We have developed Polly, an industry-leading data-centric MLOps platform for life sciences. Its technology cleans and links 26 types of biomedical data at scale into an ML-ready form. Polly delivers 45 TB of ML-ready biomedical data from ~30 different sources to customers. The platform helps data science teams to scale up by providing them with curated ML-ready biomolecular data from public and proprietary sources. Inspired by the FAIR guidelines described by the NIH, Polly's OmixAtlases allow exclusive access to curated multi-omics data that is ready for ML workflows. Polly offers 10x faster identification of therapeutic assets with high odds of success in the clinic. It has enabled the detection of multiple validated drug targets across immunology, oncology, and metabolic disorders.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Elucidata raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Elucidata's next move

See what Strategic adds

Elucidata raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.